<document id="DDI-DrugBank.d324">
    <sentence id="DDI-DrugBank.d324.s3" text="zaleplon did not affect the pharmacokinetics of ethanol.">
        <entity charOffset="0-7" id="DDI-DrugBank.d324.s3.e0" text="zaleplon" type="drug" />
        <entity charOffset="48-54" id="DDI-DrugBank.d324.s3.e1" text="ethanol" type="drug" />
        <pair ddi="false" e1="DDI-DrugBank.d324.s3.e0" e2="DDI-DrugBank.d324.s3.e1" id="DDI-DrugBank.d324.s3.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d324.s11" text="In addition, there was no pharmacodynamic interaction as a result of coadministration of zaleplon and venlafaxine ER.">
        <entity charOffset="89-96" id="DDI-DrugBank.d324.s11.e0" text="zaleplon" type="drug" />
        <entity charOffset="102-112" id="DDI-DrugBank.d324.s11.e1" text="venlafaxine" type="drug" />
        <pair ddi="false" e1="DDI-DrugBank.d324.s11.e0" e2="DDI-DrugBank.d324.s11.e1" id="DDI-DrugBank.d324.s11.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d324.s13" text="However, the pharmacodynamics of coadministration of zaleplon and promethazine have not been evaluated.">
        <entity charOffset="53-60" id="DDI-DrugBank.d324.s13.e0" text="zaleplon" type="drug" />
        <entity charOffset="66-77" id="DDI-DrugBank.d324.s13.e1" text="promethazine" type="drug" />
        <pair ddi="false" e1="DDI-DrugBank.d324.s13.e0" e2="DDI-DrugBank.d324.s13.e1" id="DDI-DrugBank.d324.s13.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d324.s15" text="Drugs That Induce CYP3A4 Rifampin: CYP3A4 is ordinarily a minor metabolizing enzyme of zaleplon.">
        <entity charOffset="25-32" id="DDI-DrugBank.d324.s15.e0" text="Rifampin" type="drug" />
        <entity charOffset="87-94" id="DDI-DrugBank.d324.s15.e1" text="zaleplon" type="drug" />
        <pair ddi="false" e1="DDI-DrugBank.d324.s15.e0" e2="DDI-DrugBank.d324.s15.e1" id="DDI-DrugBank.d324.s15.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d324.s16" text="Multiple-dose administration of the potent CYP3A4 inducer rifampin (600 mg every 24 hours, q24h, for 14 days), however, reduced zaleplon Cmax and AUC by approximately 80%.">
        <entity charOffset="58-65" id="DDI-DrugBank.d324.s16.e0" text="rifampin" type="drug" />
        <entity charOffset="128-135" id="DDI-DrugBank.d324.s16.e1" text="zaleplon" type="drug" />
        <pair ddi="true" e1="DDI-DrugBank.d324.s16.e0" e2="DDI-DrugBank.d324.s16.e1" id="DDI-DrugBank.d324.s16.p0" type="mechanism" />
    </sentence>
    <sentence id="DDI-DrugBank.d324.s22" text="Other strong selective CYP3A4 inhibitors such as ketoconazole can also be expected to increase the exposure of zaleplon.">
        <entity charOffset="49-60" id="DDI-DrugBank.d324.s22.e0" text="ketoconazole" type="drug" />
        <entity charOffset="111-118" id="DDI-DrugBank.d324.s22.e1" text="zaleplon" type="drug" />
        <pair ddi="true" e1="DDI-DrugBank.d324.s22.e0" e2="DDI-DrugBank.d324.s22.e1" id="DDI-DrugBank.d324.s22.p0" type="mechanism" />
    </sentence>
    <sentence id="DDI-DrugBank.d324.s25" text="Diphenhydramine: Diphenhydramine is reported to be a weak inhibitor of aldehyde oxidase in rat liver, but its inhibitory effects in human liver are not known.">
        <entity charOffset="0-14" id="DDI-DrugBank.d324.s25.e0" text="Diphenhydramine" type="drug" />
        <entity charOffset="17-31" id="DDI-DrugBank.d324.s25.e1" text="Diphenhydramine" type="drug" />
        <pair ddi="false" e1="DDI-DrugBank.d324.s25.e0" e2="DDI-DrugBank.d324.s25.e1" id="DDI-DrugBank.d324.s25.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d324.s26" text="There is no pharmacokinetic interaction between zaleplon and diphenhydramine following the administration of a single dose (10 mg and 50 mg, respectively) of each drug.">
        <entity charOffset="48-55" id="DDI-DrugBank.d324.s26.e0" text="zaleplon" type="drug" />
        <entity charOffset="61-75" id="DDI-DrugBank.d324.s26.e1" text="diphenhydramine" type="drug" />
        <pair ddi="false" e1="DDI-DrugBank.d324.s26.e0" e2="DDI-DrugBank.d324.s26.e1" id="DDI-DrugBank.d324.s26.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d324.s36" text="Drugs That Alter Renal Excretion Ibuprofen: Ibuprofen is known to affect renal function and, consequently, alter the renal excretion of other drugs.">
        <entity charOffset="33-41" id="DDI-DrugBank.d324.s36.e0" text="Ibuprofen" type="drug" />
        <entity charOffset="44-52" id="DDI-DrugBank.d324.s36.e1" text="Ibuprofen" type="drug" />
        <pair ddi="false" e1="DDI-DrugBank.d324.s36.e0" e2="DDI-DrugBank.d324.s36.e1" id="DDI-DrugBank.d324.s36.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d324.s37" text="There was no apparent pharmacokinetic interaction between zaleplon and ibuprofen following single dose administration (10 mg and 600 mg, respectively) of each drug.">
        <entity charOffset="58-65" id="DDI-DrugBank.d324.s37.e0" text="zaleplon" type="drug" />
        <entity charOffset="71-79" id="DDI-DrugBank.d324.s37.e1" text="ibuprofen" type="drug" />
        <pair ddi="false" e1="DDI-DrugBank.d324.s37.e0" e2="DDI-DrugBank.d324.s37.e1" id="DDI-DrugBank.d324.s37.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d324.s38" text="This was expected because zaleplon is primarily metabolized and renal excretion of unchanged zaleplon accounts for less than 1% of the administered dose.">
        <entity charOffset="26-33" id="DDI-DrugBank.d324.s38.e0" text="zaleplon" type="drug" />
        <entity charOffset="93-100" id="DDI-DrugBank.d324.s38.e1" text="zaleplon" type="drug" />
        <pair ddi="false" e1="DDI-DrugBank.d324.s38.e0" e2="DDI-DrugBank.d324.s38.e1" id="DDI-DrugBank.d324.s38.p0" />
    </sentence>
</document>